ArticleJournal of thoracic disease2026
Prognostic value as metabolic tumor activity on
Article in Journal of thoracic disease, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
12 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Thymic epithelial tumors (TETs) are rare neoplasms; however, optimal predictors after initial treatment are unclear. Methods: A total of 108 consecutive patients with TETs classified as thymoma or thymic carcinoma (TC) who received Results: Univariate analysis identified performance status (PS), smoking, disease stage, histology, SUVmax, MTV, and TLG as significant predictors of progression-free survival (PFS) and overall survival (OS). In the multivariate analysis, TLG was an independent prognostic factor for predicting worse PFS, and histology emerged as a significant predictor for OS. In patients with thymoma, univariate analysis identified disease stage, SUVmax, MTV, and TLG as significant predictors for PFS but not OS. In patients with TC, univariate analysis identified PS, disease stage, smoking status, SUVmax, MTV, and TLG as significant predictors for both PFS and OS. Conclusions: Indicators of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.